Acquired Asset Jusuru International operates under Modere since 2017, indicating an established distribution network and broader product ecosystem to leverage for cross-selling Liquid BioCell and related wellness offerings.

Science Backed With over 37 clinical studies and multiple patents, emphasize credibility to open conversations with retail partners, clinics, and wellness programs seeking evidence-based nutraceuticals for joint health and anti-aging.

Growth Footprint Mid-size company with 50–200 employees and revenue in the 50–100 million range presents opportunities to target mid-market distributors, regional retailers, and e-commerce collaborations seeking scalable wellness brands.

Product Differentiator Liquid BioCell and cGMP-compliant manufacturing position Jusuru as a premium, science-driven alternative in anti-aging and joint health, enabling pitches to premium retailers, spas, and healthcare channels.

Strategic Synergy Existing Indirect Sales Network via Independent Representatives can be extended with targeted training, co-branded campaigns, and performance-based incentives to accelerate recruitment and market penetration through partnered channels.